(-)-Phenserine attenuates soman-induced neuropathology

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Organophosphorus (OP) nerve agents are chemical weapons that cause irreversible inhibition of acetylcholinesterase (AChE), leading to neurotoxicity and brain damage.
• Current countermeasures for OP nerve agent exposure have limited efficacy in preventing brain damage.
• (-)-Phenserine, a reversible AChE inhibitor with a known safety profile, has neuroprotective properties and preferentially enters the central nervous system (CNS).

Purpose of the Study:

• To evaluate the neuroprotective potential of (-)-phenserine against soman, a potent OP nerve agent.
• To investigate the mechanisms underlying (-)-phenserine's protective effects against soman-induced neurotoxicity.
• To assess the therapeutic window and efficacy of (-)-phenserine as a pretreatment or post-treatment strategy.

Main Methods:

• Neuronal cell cultures and rodent models were used to assess soman-induced neurotoxicity.
• (-)-Phenserine was administered as a pretreatment or post-treatment to evaluate its protective effects on neuronal survival, motor function, and mortality.
• Gene expression analysis was performed to elucidate the molecular mechanisms of protection.

Main Results:

• (-)-Phenserine demonstrated significant neuroprotection against soman-induced neuronal cell death in both pretreatment and post-treatment paradigms.
• Soman-exposed animals treated with (-)-phenserine showed improved motoric movement and reduced mortality when given as a pretreatment.
• Gene expression analysis revealed that (-)-phenserine pretreatment upregulated neuroprotective genes and reversed soman-induced elevation of Homer1 expression.

Conclusions:

• (-)-Phenserine exhibits significant neuroprotective effects against soman-induced neurotoxicity in preclinical models.
• The compound's ability to protect neurons, improve motor function, and reduce mortality suggests its potential as a novel countermeasure.
• Further evaluation of (-)-phenserine is warranted as a protective strategy against organophosphorus nerve agent exposure.